Question 59

The cap of a prescription bottle requires compliance with the Poison Prevention Packaging Act.

The Poison Prevention Packaging Act mandates that certain substances, including prescription medications, must be packaged in child-resistant containers. This requirement primarily focuses on the cap of the prescription bottle, ensuring that it cannot be easily opened by children.

A) Label

While labeling is important for providing information about the medication, it is not specifically mandated by the Poison Prevention Packaging Act for child safety. The act focuses on the packaging mechanism, particularly the cap, rather than the labeling details.

B) Cap

The cap is the critical feature that must comply with the Poison Prevention Packaging Act. This regulation aims to prevent accidental poisoning in children by ensuring that medication containers are equipped with child-resistant caps that require a specific method to open.

C) Color

The color of a prescription bottle does not have any compliance requirements under the Poison Prevention Packaging Act. The act is concerned with safety features rather than aesthetic aspects like color.

D) Size

Size does not pertain to the compliance requirements of the Poison Prevention Packaging Act. The act focuses on how medications are secured against child access, which is not influenced by the size of the bottle.

Conclusion

The cap is the essential component that must adhere to the regulations of the Poison Prevention Packaging Act, ensuring child safety. All other options, including the label, color, and size, do not address the specific requirements set forth by the act for preventing accidental poisoning in children. Thus, option B is the only correct answer.